These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 28236781)
21. Equipercentile linking of the BPRS and the PANSS. Leucht S; Rothe P; Davis JM; Engel RR Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639 [TBL] [Abstract][Full Text] [Related]
22. Differential patterns of responding among three groups of chronic, psychotic, forensic outpatients. Bannatyne LA; Gacono CB; Greene RL J Clin Psychol; 1999 Dec; 55(12):1553-65. PubMed ID: 10855488 [TBL] [Abstract][Full Text] [Related]
23. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Byerly MJ; Nakonezny PA; Rush AJ Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269 [TBL] [Abstract][Full Text] [Related]
24. Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. Zarate CA; Tohen M J Clin Psychiatry; 2000 Jan; 61(1):33-8. PubMed ID: 10695644 [TBL] [Abstract][Full Text] [Related]
25. Concordance of patient and clinical ratings of symptom severity and change of psychotic illness. Rabinowitz J; Levine SZ; Medori R; Oosthuizen P; Koen L; Emsley R Schizophr Res; 2008 Mar; 100(1-3):359-60. PubMed ID: 18077138 [No Abstract] [Full Text] [Related]
26. Differentiating adolescents at clinical high risk for psychosis from psychotic and non-psychotic patients with the Rorschach. Ilonen T; Heinimaa M; Korkeila J; Svirskis T; Salokangas RK Psychiatry Res; 2010 Sep; 179(2):151-6. PubMed ID: 20483480 [TBL] [Abstract][Full Text] [Related]
27. Object relations and reality testing in schizophrenia, bipolar disorders, and healthy controls: differences in profiles and clinical correlates. Hansen CF; Torgalsbøen AK; Røssberg JI; Andreassen OA; Bell MD; Melle I Compr Psychiatry; 2012 Nov; 53(8):1200-7. PubMed ID: 22578986 [TBL] [Abstract][Full Text] [Related]
28. [Use of Hunperdal Richter in psychiatry]. Magyar GI; Fadgyas I Neuropsychopharmacol Hung; 2009 Jun; 11(2):111-5. PubMed ID: 19827319 [TBL] [Abstract][Full Text] [Related]
30. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Valenstein M; Kavanagh J; Lee T; Reilly P; Dalack GW; Grabowski J; Smelson D; Ronis DL; Ganoczy D; Woltmann E; Metreger T; Wolschon P; Jensen A; Poddig B; Blow FC Schizophr Bull; 2011 Jul; 37(4):727-36. PubMed ID: 19933540 [TBL] [Abstract][Full Text] [Related]
31. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients. Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740 [TBL] [Abstract][Full Text] [Related]
32. Thought disorder in children at risk for psychosis. Arboleda C; Holzman PS Arch Gen Psychiatry; 1985 Oct; 42(10):1004-13. PubMed ID: 4037984 [TBL] [Abstract][Full Text] [Related]
33. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial. Kulkarni J; Gavrilidis E; Gwini SM; Worsley R; Grigg J; Warren A; Gurvich C; Gilbert H; Berk M; Davis SR JAMA Psychiatry; 2016 Sep; 73(9):947-54. PubMed ID: 27438995 [TBL] [Abstract][Full Text] [Related]
34. [Neurological soft signs: meaning and relevance along the course of psychiatric illness. An objective and rapid screening for psychosis?]. Dimitri-Valente G; Rigucci S; Manfredi G; Girardi P; Ferracuti S Riv Psichiatr; 2012; 47(6):465-78. PubMed ID: 23160107 [TBL] [Abstract][Full Text] [Related]
35. Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder. Stewart M; DelBello MP; Versavel M; Keller D J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):635-40. PubMed ID: 20035581 [TBL] [Abstract][Full Text] [Related]
36. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835 [TBL] [Abstract][Full Text] [Related]
37. Effects of chlorpromazine on sleep quality, clinical and emotional measures among patients with schizophrenia. Meng Q; Li R; Hou F; Zhang Q Clin Neurol Neurosurg; 2018 Feb; 165():134-138. PubMed ID: 29421173 [TBL] [Abstract][Full Text] [Related]
38. Covariation between motor signs and negative symptoms in drug-naive subjects with schizophrenia-spectrum disorders before and after antipsychotic treatment. Peralta V; de Jalón EG; Campos MS; Cuesta MJ Schizophr Res; 2018 Oct; 200():85-91. PubMed ID: 28864283 [TBL] [Abstract][Full Text] [Related]
39. Antipsychotic efficacy of fluperlapine. An open multicenter trial. Woggon B; Angst J; Bartels M; Heinrich K; Hippius H; Koukkou M; Krebs E; Küfferle B; Müller-Oerlinghausen B; Pöldinger W Neuropsychobiology; 1984; 11(2):116-20. PubMed ID: 6148712 [TBL] [Abstract][Full Text] [Related]
40. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore. Sim K; Su A; Chan YH; Shinfuku N; Kua EH; Tan CH Psychiatry Clin Neurosci; 2004 Jun; 58(3):324-9. PubMed ID: 15149301 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]